Analyst Price Target is $15.50
▲ +140.31% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for RenovoRx in the last 3 months. The average price target is $15.50, with a high forecast of $16.00 and a low forecast of $15.00. The average price target represents a 140.31% upside from the last price of $6.45.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in RenovoRx.